Non-Small Cell Lung Cancer
Reports outline non-small cell lung cancer study findings from J. Hong and colleagues
Published in Health Risk Factor Week, November 6th, 2007
According to recent research published in the Japanese Journal of Clinical Oncology, " Nail toxicity is one of the most frequent non-hematologic toxicities of docetaxel and often deteriorates patients' quality of life, leading to treatment discontinuation. To define the incidence of nail change as well as its association with specific risk factors, we prospectively investigated data of 84 consecutive patients with advanced non-small cell lung cancer who received first-line docetaxel/cisplatin combination chemotherapy."
"Chemotherapy-naive patients were treated with docetaxel, either 3-weekly or weekly, in combination with cisplatin. All patients received adequate...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
More Articles from Health Risk Factor Week
- Anthrax
MARCOR Responds to Deadly MRSA Outbreak - Aspergillosis
Researchers from Aristotle University, Department of Pediatrics provide details of new studies and findings in the area of aspergillosis in children - Aspergillosis
Studies from University Hospital reveal new findings on aspergillosis - Aspergillosis Therapy
Study data from University of Pisa provide new insights into aspergillosis therapy - Biomedicine
New biomedicine research has been reported by scientists at University of Sao Paulo, Institute of Biomedical Science - Bird Flu
Bird flu finds children's lungs faster - More from this issue of Health Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
